drugset / Trial / NCT00594698

Familiarization and Safety Study of PB127 Ultrasound Contrast Agent

NCT00594698 ↗

Phase 2/3 Completed 150 enrolled Point Biomedical
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to evaluate preparation and administration of PB127, echocardiographic images obtained during PB127 administration, and evaluate the safety of PB127.

Timeline

Start
2002-02
Primary completion
2003-09
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Subject PB127 Diagnostic / imaging agent 0.175 mg/kg Intravenous